Dynamic changes in purine catabolism in patients with acute coronary syndrome that underwent percutaneous coronary intervention
Open Access
- 1 January 2019
- journal article
- research article
- Vol. 10 (1), 86-91
- https://doi.org/10.22088/CJIM.10.1.86
Abstract
Background: Cardiovascular diseases are global problems. They are causes of death in about 43% of people worldwide and may become the most widespread reason of death by 2020. The prognosis is directly dependent to immediate diagnosis and on time treatment. Introduction of new biochemical markers as the early diagnosis of complications after coronary revascularization is very important in this period. Herein, we assayed the changes of purine catabolites in patients with acute coronary syndrome (ACS) before and after percutaneous coronary intervention (PCI) in comparison with control group. Methods: Thirty five ACS patients (20 males and 15 females) were included (57 +/- 17 years old) in the study. The determination of intermediates of purine catabolism as guanine, hypoxanthine (GCS), adenine, xanthine (ICc) and uric acid (MK) were assayed before and 3 days after PCI. Conditionally, 35 healthy-matched persons were included in the control group. Purine catabolites were determined in plasma through the method of Oreshnikov E.V (2008). Results: In ACS patients, prior to PCI, there was a tendency to increase the concentration of guanine (P:o.001), hypoxanthine (P=0.002) adenine (P=0.0003), xanthine (P=0.000003) and uric acid (P=-0.000001) relative to the upper limits of normal ranges. And on the third day after PCI, there was the second tendency to increase the levels of guanine (P=0.000001), hypoxanthine (P:o.000001) adenine (P:o.0000001), xanthine (P0.000001) and uric acid (P:o.0000001) relative to upper limits of normal ranges. Conclusion: Increment of plasma purine catabolites can be a marker of inflammation and instability of coronary artery plaques and may be used as a restenosis marker in patients with history of PCI.Keywords
This publication has 14 references indexed in Scilit:
- Inosine and hypoxanthine as novel biomarkers for cardiac ischemia: From bench to point-of-careExperimental Biology and Medicine, 2015
- Comparison of Newer-Generation Drug-Eluting With Bare-Metal Stents in Patients With Acute ST-Segment Elevation Myocardial InfarctionJACC: Cardiovascular Interventions, 2014
- P2X and P2Y nucleotide receptors as targets in cardiovascular diseaseFuture Medicinal Chemistry, 2013
- The Role of Uric Acid as an Endogenous Danger Signal in Immunity and InflammationCurrent Rheumatology Reports, 2011
- Hyperuricemia and coronary heart disease: A systematic review and meta‐analysisArthritis Care & Research, 2010
- Nucleotide- and nucleoside-converting ectoenzymes: Important modulators of purinergic signalling cascadeBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2008
- Neutrophils as Sources of Extracellular Nucleotides: Functional Consequences at the Vascular InterfaceTrends in Cardiovascular Medicine, 2008
- Activation of Platelet Function Through G Protein–Coupled ReceptorsCirculation Research, 2006
- Endogenous adenosine produced during hypoxia attenuates neutrophil accumulation: coordination by extracellular nucleotide metabolismBlood, 2004
- Total ischemia in dog hearts, in vitro. 1. Comparison of high energy phosphate production, utilization, and depletion, and of adenine nucleotide catabolism in total ischemia in vitro vs. severe ischemia in vivo.Circulation Research, 1981